BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16708082)

  • 1. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL; Grodzicki T; Palmer AJ; Beevers DG; Webster J; Bulpitt CJ;
    J Hum Hypertens; 2006 Jun; 20(6):451-9. PubMed ID: 16708082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL; Grodzicki T; Beevers DG; Webster J; Jokelainen JJ; Bulpitt CJ
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population.
    Chen R; Bai K; Lu F; Zhao Y; Pan Y; Wang F; Zhang L
    Clin Interv Aging; 2019; 14():1657-1662. PubMed ID: 31571845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.
    Antikainen R; Grodzicki T; Palmer AJ; Beevers DG; Coles EC; Webster J; Bulpitt CJ
    J Hum Hypertens; 2003 Mar; 17(3):159-64. PubMed ID: 12624605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
    Edison ES; Yano Y; Hoshide S; Kario K
    Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.
    Porthan K; Niiranen TJ; Varis J; Kantola I; Karanko H; Kähönen M; Nieminen MS; Salomaa V; Huikuri HV; Jula AM
    J Hypertens; 2015 Jun; 33(6):1284-90. PubMed ID: 25764049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
    Okin PM; Gerdts E; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B; Devereux RB;
    Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G
    J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.